Sarepta (SRPT) Trades Higher on Eteplirsen Phase II Update, Analyst Comments
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- Wall St futures rise as Treasury yields cool, oil slips
- Oil slips as Mideast exports, G7 stockpile ease supply concerns
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 46.55 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $46.55 | 52 Week High | $45.58 | |||
| Open | $46.55 | 52 Week Low | $37.82 | |||
| Day High | $46.55 | P/E | N/A | |||
| Day Low | $46.55 | EPS | $0.00 | |||
| Volume | 30,360 | |||||
| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 17.49 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.49 | 52 Week High | $63.73 | |||
| Open | $17.49 | 52 Week Low | $8.00 | |||
| Day High | $17.49 | P/E | N/A | |||
| Day Low | $17.49 | EPS | $-5.69 | |||
| Volume | 1,903 | |||||
